RxDoctor Payments Data

Jennifer McGee

Family · Fenton, MINPI 1386353522

Payments from drug & device makers

$3,196in general payments, 2019–2025

Across 141 payments — averaging $22.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$543
  • AstraZeneca$523
  • AbbVie$519
  • Pfizer$429
  • Axsome Therapeutics, Inc.$185
  • Exact Sciences$163
  • plus $835 from 19 others

What the payments were for

  • Food & beverage$3,196100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,196 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$14,881
Medicare patients
68
Services billed
287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide15$12,967
Fluticasone Propionate53$667
Metoprolol Succinate26$654
Pantoprazole Sodium31$637
Ipratropium Bromide26$602
Gabapentin40$527
Losartan Potassium28$482
Albuterol Sulfate HfaAlbuterol Sulfate17$466
Amlodipine Besylate33$415
Sertraline Hcl15$374
Lisinopril41$328
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$318
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$302
Pregabalin14$292
Montelukast Sodium25$291

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$72$12,96715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,657 family providers in Michigan.

Other family in Fenton

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →